Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM Administered Subcutaneously to Hay Fever Patients

NCT02156791 is registered in ClinicalTrials.gov with BioTech Tools S.A. as lead sponsor.

NCT NCT02156791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02156791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM Administered Subcutaneously to Hay Fever Patients
Lead sponsor
BioTech Tools S.A.
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2013
Completion date
December 31, 2013
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hay fever